Skip to main content

Table 1 Clinical characteristic of the hepatocellular carcinoma patients

From: Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma

Patient ID

Age

Sex

Pathological type

Size of tumor

BCLC stage

HBsAg (IU/mL)

HBV-DNA (IU/mL)

AFP (ng/mL)

ALT(U/L)

AST(U/L)

1

58

M

Moderately differentiated

32 × 22 mm

A

> 180

8.69E+3

1073

40.7

33.3

2

47

M

Poorly differentiated

28 × 25 mm

A

29.86

1.06E+2

1.43

248.2

183.2

3

64

M

Moderately differentiated

77 × 71 mm

B

> 180

1.08E+5

110

25.8

55.1

4

60

M

Moderately to poorly differentiated

106 × 73 mm

C

159.58

3.24E+2

16.09

33.6

46

5

61

M

Moderately differentiated

16 × 17 mm

O

> 250

5.89E+2

766.5

16

12.9

6

46

M

Moderately to poorly differentiated

27 × 28 mm

A

> 180

2.60E+5

4371

37.2

25.7

7

38

M

Moderately differentiated

25 × 24 mm

A

251.9

< 100

0.746

35

43

8

76

M

S8:Well-differentiated

S7:Moderately to poorly differentiated

15 × 13 mm

O

1.17

< 100

unknown

28

28

9

57

M

Moderately differentiated

27 × 19 mm

A

> 250

5.05E+03

3.129

20

16

10

64

M

Well-differentiated

24 × 20 mm

A

2165

< 100

5.06

24

22

11

53

M

Moderately differentiated

62 × 63 mm

B

1070

4.21E+05

3.516

32

53

12

45

M

Moderately differentiated

81 × 51 mm

B

> 180

1.21E+2

855.5

23.5

19.2